Trials / Unknown
UnknownNCT03631121
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus
Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study will assess the glycemic variationusing continuous glucose monitoring system in type 2 diabetic patients with euglycemia control respectively when patients was treated with Basalin and one week after changing the insulin into Lantus.
Detailed description
The participants will take continuous glucose monitoring system for 3 days when they change the insulin into Lantus after reach euglycemia control with Basalin treatment for one week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Basalin to Lantus | continuous glucose monitoring system will used twice when patients are using Basalin and Lantus respectively to assess glycemic variation. |
Timeline
- Start date
- 2018-08-15
- Primary completion
- 2018-12-31
- Completion
- 2019-07-30
- First posted
- 2018-08-15
- Last updated
- 2019-06-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03631121. Inclusion in this directory is not an endorsement.